Analyst rating
Based on 1 analyst giving stock ratings to HYBIO PHARMACEUTIC in the past 3 months.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Strong buy
1
Buy
0
Hold
0
Sell
0
Strong sell
0
EPS
Forecast
2017
2018
2019
2020
2021
2023
2024
2025
2026
−0.80
−0.40
0.00
0.40
0.80
Reported
Estimate
Currency: CNY
2017
2018
2019
2020
2021
2023
2024
2025
2026
Reported
—
—
—
−0.58
—
—
—
Estimate
−0.05
0.79
−0.22
−0.49
−0.20
0.45
0.68
Surprise
—
—
—
−18.37%
—
—
—
Revenue
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
0.00
30.00 M
60.00 M
90.00 M
120.00 M
Reported
Estimate
Currency: CNY
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Reported
105.00 M
120.00 M
—
—
—
Estimate
—
—
—
—
—
Surprise
—
—
—
—
—
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.